bullish
An Update on Medtronic's Tender Offer of Eoflow
433 Views25 Jul 2023 22:00
In this insight, we provide an update of Medtronic's tender offer of Eoflow. We continue to believe there is 95%+ probability of this M&A getting completed at the tender offer price of 30,000 won.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Eoflow: Ozempic and Wegovy Reducing Need for Disposable Insulin Injection Devices + Ongoing Lawsuit?05 Oct 2023
- Eoflow's US Subsidiary (Nephria Bio)'s Technology in MXene Advanced Material21 Aug 2023
- Insulet's Lawsuit Against Eoflow, Medtronic's Tender Offer, and Eoflow's "Special Sauce"09 Aug 2023
- Medtronic's M&A, Tender Offer, and Taking Private of Eoflow30 May 2023
- Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?25 Jun 2018
- Autonomous Driving- The Tesla Delusion06 Apr 2018
x